Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Benzer Materyaller

• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
  Yazar:: Taher AT, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-12-01)
• Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox
  Yazar:: Taher, Ali T, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia
  Yazar:: Trachtenberg, Felicia, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
  Yazar:: Kontoghiorghe, Christina N, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
  Yazar:: Ansari, Shahla, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)